SRF
CEROW

Silver Rock Financial’s CERo Therapeutics Warrants CEROW Stock Holding History

Silver Rock Financial’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,224
Closed -$163 – 28
2025
Q3 		$163 Hold
12,224
– – ﹤0.01% 29
2025
Q2 		$291 Hold
12,224
– – ﹤0.01% 30
2025
Q1 		$177 Hold
12,224
– – ﹤0.01% 29
2024
Q4 		$101 Hold
12,224
– – ﹤0.01% 28
2024
Q3 		$62 Hold
12,224
– – ﹤0.01% 39
2024
Q2 		$246 Hold
12,224
– – ﹤0.01% 44
2024
Q1 		$834 Hold
12,224
– – ﹤0.01% 43
2023
Q4 		$306 Hold
12,224
– – ﹤0.01% 50
2023
Q3 		$875 Sell
12,224
-10,896
-47% -$779 0.01% 58
2023
Q2 		$1.41K Hold
23,120
– – ﹤0.01% 79
2023
Q1 		$696 Hold
23,120
– – ﹤0.01% 115
2022
Q4 		$996 Buy
+23,120
New +$1.22K ﹤0.01% 168

Other funds holding CEROW

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Silver Rock Financial's CEROW Position: Q4 2025 in Review

Silver Rock Financial sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 12,224 shares — an estimated $163 sold.

Silver Rock Financial first reported a position in CEROW in Q4 2022 and held it in 12 quarters. The position peaked at $1.41K in Q2 2023. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.

  • Silver Rock Financial reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
  • Silver Rock Financial sold 12,224 CERo Therapeutics Warrants shares in Q4 2025, an estimated $163.
  • Silver Rock Financial first reported a position in CERo Therapeutics Warrants in Q4 2022 and held it in 12 quarters.
  • Silver Rock Financial's CERo Therapeutics Warrants position peaked at $1.41K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.

Based on Silver Rock Financial's 13F filing for Q4 2025, filed 17 Feb 2026.